Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: clinical and immunological results. [electronic resource]
Producer: 20030926Description: 1117-23 p. digitalISSN:- 1043-0342
- Adult
- Aged
- Antigen-Presenting Cells -- immunology
- Antigens, Neoplasm -- immunology
- B7-1 Antigen -- genetics
- Breast Neoplasms -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- adverse effects
- Colony-Stimulating Factors -- immunology
- Cytokines -- biosynthesis
- Female
- Genetic Vectors
- HLA-A2 Antigen -- immunology
- Histocompatibility Testing
- Humans
- Isoantigens -- immunology
- Middle Aged
- Neoplasm Metastasis
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.